Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Genscript Biotech ( (HK:1548) ) has issued an announcement.
Genscript Biotech Corporation has established a Risk Management and ESG Committee to oversee the company’s risk management and environmental, social, and governance (ESG) strategies. This new committee will also have a Sub-committee focused on data security and geopolitical resilience, highlighting the company’s proactive approach to addressing emerging risks. Such a move underscores Genscript Biotech’s commitment to robust governance and strategic oversight, potentially enhancing its industry positioning by ensuring rigorous risk management and ESG compliance.
More about Genscript Biotech
YTD Price Performance: -2.36%
Average Trading Volume: 5,850
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.04B
Learn more about 1548 stock on TipRanks’ Stock Analysis page.
